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The purpose of this study was to determine whether intravaginal prosta-
glandin F2a (PGF2a) would be effective for the treatment of metritis or pyometra
in the bitch. Seventeen bitches with metritis or pyometra were treated with PGF2a.
Prostaglandin F2a (150 µg/kg body weight) was administered once or twice daily
by infusing 0.3 ml per 10 kg body wt into the vaginal lumen. Bitches were also
treated with amoxicillin (15 mg/kg body wt/48 h) and/or gentamicin (4 mg/kg
body wt/day) administered as intramuscular (i.m.) injections. Fifteen bitches were
treated successfully with intravaginally administered PGF2a for 3 to 12 days and
with intramuscularly administered antibiotics for 4 to 12 days. Success of treat-
ment was judged by cessation of vaginal discharge, the absence of fluid in the
uterus as determined by ultrasonography, and the overall health status of the ani-
mal. As two bitches with pyometra showed clinical deterioration in spite of medi-
cal treatment, ovariohysterectomy was performed after the first and the second
treatment, respectively. No side effects (salivation, vomiting, diarrhoea, hyper-
pnoea, ataxia, urination, anxiety, pupillary dilatation followed by contraction)
were observed after PGF2a treatment. The disease did not recur during the subse-
quent oestrous cycles within 12 months after the initial treatment. The results
demonstrate that intravaginal administration of PGF2a was effective in 13 dogs
(86.6%) with metritis or pyometra, and caused no side effects. Although the study
was based on a relatively small number of cases, it is concluded that prostaglandin
F2a can be a useful means of treating bitches with metritis or pyometra. However,
in severe cases of pyometra ovariohysterectomy is needed.
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Metritis usually occurs after an oestrus accompanied by mating or after
parturition, and can be acute or chronic. Pyometra occurs during dioestrus
(Sokolowski, 1980). The direct cause of these conditions is not known but pro-
gesterone can stimulate the development of cystic endometrial hyperplasia and
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fluid accumulation within the uterus in the case of pyometra (Johnson, 1993). At
the same time, ascending, haematogenic, or lymphogenic bacterial infection of
the uterus may play an important role (Nelson and Feldman, 1986). Sometimes
medroxyprogesterone acetate or oestradiol benzoate treatment causes cystic en-
dometrial hyperplasia and pyometra (Burke, 1986; Johnson, 1993).
Prostaglandin F2a and systemic antibiotics are the most effective medical
therapy for metritis and pyometra in the bitch (Sokolowski, 1980; Nelson and
Feldman, 1982; Meyers-Wallen et al., 1986). However, PGF2a administered par-
enterally can cause side effects such as salivation, vomiting, diarrhoea, hyper-
pnoea, ataxia, urination, anxiety and pupillary dilatation followed by contrac-
tion. These side effects may last for up to 120 min after PGF2a administration
(Sokolowski and Geng, 1977; Nelson et al., 1982).
The purpose of this study was to determine whether intravaginal PGF2a
administration would be effective for the treatment of metritis (post-oestrus) and
pyometra (dioestrus) in the bitch. Since PGF2a has not been approved for intra-
vaginal use in the bitch, owners were informed that the use of PGF2a for treating
canine metritis and pyometra was experimental, and this treatment was initiated
only after we had obtained the owners approval.
Materials and methods
Seventeen privately owned bitches of different breeds with metritis (post-
oestrus) or pyometra (dioestrus) were presented to the FeliCaVet Private Veteri-
nary Clinic because of illness. They ranged in age from 2 to 11 years. The diag-
noses were based on clinical signs (depression, lethargy, anorexia, polyuria,
polydipsia, weakness, vaginal discharge if the cervix was patent), findings from
abdominal palpation (uterine enlargement), vaginoscopy, and ultrasonography
(Zöldág et al., 1991). Ultrasonography of the uterus was performed with a
7.5 MHz linear-array transducer (Scanner 450 VET, Pie Medical, Maastricht,
The Netherlands). In some cases (closed-cervix pyometra) clinical chemistry
such as white blood cell count and differential blood count were used to deter-
mine the degree of inflammatory processes. The bitches were allocated to the
following three groups (Table 1) based on the clinical criteria described below:
Group 1: post-oestrous chronic metritis (n = 6; age: 3.0 ± 1.0 years)
The cross-sectional diameter of the fluid-filled uterine horns just before
the cervix (measured by transabdominal ultrasonography) was less than 1.5
(range: 0.91.5) cm. Mucous, bloody, purulent, or olive-drab vaginal discharge
was also present. The clinical status of the bitches was otherwise normal.
INTRAVAGINAL PGF2a FOR TREATMENT OF METRITIS AND PYOMETRA IN THE BITCH 105
Acta Veterinaria Hungarica 47, 1999
Table 1
Recovery rate in bitches receiving intravaginal PGF2a and parenteral antibiotic treatment
Diagnosis
Number
of treatments
Mean
Number
of days
Mean
Recovered Diameter
of the uterine horn
(n) (range) (range) N Day cm (range)
Group 1
Endometritis,
metritis (n = 6)
4.2
(36)
4.0
(35)
6 D 0
D 2
D F
1.1 (0.91.5)
1.0 (0.81.1)
0.7 (0.60.8)
Group 2
Open-cervix
pyometra (n = 6)
6.5
(67)
5.8
(57)
6 D 0
D 4
D F
2.0 (1.82.5)
1.3 (1.21.4)
0.8 (0.71.0)
Group 3
Closed-cervix
pyometra (n = 5)a
13.3b
(1016)
10.0b
(712)
3b D 0
D 4
D F
2.0 (1.82.5)
1.3 (1.21.4)
0.8 (0.71.0)
aNumber of bitches treated in Group 3; bIn two cases of closed-cervix pyometra, ovariohysterec-
tomy was performed on the first and second day of the treatment, respectively, because of poor
general health status; D 0: first ultrasound examination; D F: final ultrasound examination
Group 2: open-cervix pyometra in dioestrus (n = 6; age: 3.5 ± 1.9 years)
The diameter of the fluid-filled uterine horns was greater than 1.5 (range:
1.82.5) cm as determined by ultrasonography. There was a bloody, dark brown
or purulent vaginal discharge. Health status was normal (n = 3) to suboptimal
(n = 3) as judged by degree of depression, anorexia, polyuria, polydipsia, and
elevation of body temperature (39.339.8 °C).
Group 3: closed-cervix pyometra in dioestrus (n = 5; age: 6.4 ± 2.9 years)
The diameter of the fluid-filled uterine horns was greater than 1.5 (range
1.82.5) cm; the total white blood cell count was elevated (exceeding 20,000 cells
per mm3), and there was marked neutrophilia. The health status was normal (n =
1), suboptimal (n = 2) and poor (n = 2) as judged by the degree of depression, ano-
rexia, polyuria, polydipsia, and elevation of body temperature (39.339.8 °C). In
each case ovariohysterectomy, the traditional curative treatment for metritis and
pyometra, was discussed with the owners. Although pyometra can recur within 27
months of successful medical management in >70% of bitches (Sokolowski and
Geng, 1977) and the owners did not want to have most of the bitches bred again,
medical treatment was requested in each reported case. All animals were treated
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with broad-spectrum bactericidal antibiotics [Clamoxyl L.A. inj. (amoxicillin),
SmithKline Beecham, or Vetrigent inj. A.U.V. (gentamicin), Phylaxia-Sanofi, Bu-
dapest, Hungary] intramuscularly and with PGF2a (Enzaprost F inj. A.U.V.,
Sanofi-Chinoin, Budapest, Hungary) intravaginally. Prostaglandin F2a therapy
(150 µg/kg of body wt) was administered with the help of a sterilised plastic
catheter and infusing PGF2a (0.3 ml/10 kg of body wt) once or twice daily. Imme-
diately after PGF2a infusion the hindquarters of the animals were raised for 3 to
5 min in order to minimise retrograde loss of PGF2a. Animals with normal health
status were treated with long-acting amoxicillin (15 mg/kg body wt/48 h) 2 to
5 times for 4 to 10 days. If after the second treatment there was no improvement in
clinical signs (general health status, body temperature), gentamicin therapy
(4 mg/kg body wt/day) was given for 8 days (n = 3). Animals with suboptimal or
poor health status were treated with gentamicin daily for 10 days. Intravenous fluid
therapy with balanced electrolyte solution (lactated Ringers solution) was given to
bitches with poor health status on admission (n = 2) and was repeated daily until
needed. During the treatment period, a complete physical examination was per-
formed daily to monitor actual health status and clinical response to treatment.
Every second day uterine diameter was estimated by ultrasonography. Animals
were considered to have recovered if no vaginal discharge was observed, there was
an absence of fluid in the uterus as judged by ultrasonography, and if the animals
had a normal overall health status.
Results
The results of PGF2a treatments are shown in Table 1. With the exception of
two bitches with pyometra, the treated animals recovered within 3 to 12 days. As
two bitches (5 and 11 years old, respectively) showed clinical deterioration,
ovariohysterectomy was carried out after the first and the second treatment, re-
spectively. Both bitches recovered after ovariohysterectomy. No side effects
(salivation, vomiting, diarrhoea, hyperpnoea, ataxia, urination, anxiety, and pupil-
lary dilatation followed by contraction) were found after intravaginal PGF2a treat-
ments. The haematological abnormalities seen in group 3 had also normalised by
the end of treatment. The disease did not recur among the recovered animals dur-
ing the subsequent oestrous cycles within 12 months after the initial treatment.
Discussion
In the medical management of metritis or pyometra, PGF2a has been ac-
cepted as a medical alternative to ovariohysterectomy because it causes luteolysis,
myometrial contraction, and dilatation of the cervix. In the present study intravagi-
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nally administered prostaglandin therapy resulted in the dilatation of the cervix in
3 out of 5 bitches with closed-cervix pyometra. Responses to PGF2a led to the ex-
pulsion of the uterine contents and thus helped restore normal uterine anatomy and
function (Lein, 1986). Different subcutaneous treatment schedules with varying
dosages of PGF2a have been used for the treatment of metritis or pyometra in
bitches. To minimise the side effects, the original doses (5001000 µg/kg) of natu-
ral prostaglandin (Dinoprost) were decreased (250 µg/kg). This was very important
because the LD50 (5.13 mg/kg) in the bitch is low and gives a narrow therapeutic
index (Sokolowski and Geng, 1977). At the same time the effectiveness of the drug
did not decrease with this lower dose and the number of treatments did not have to
be increased (Sokolowski, 1980). Others found satisfactory results after using a
much lower dose (100 µg/kg/treatment; Nelson et al., 1982). A dose between 100
and 250 µg/kg (Meyers-Wallen et al., 1986; Nelson and Feldman, 1986; Johnson,
1992; Johnson, 1993) once or twice daily was recommended. According to Brown
(1985) 200 to 250 µg/kg is more effective but side effects are still present. Arnold
et al. (1988) and Nolte et al. (1993) reported that 20 µg/kg PGF2a administered two
(Nolte et al., 1993) to three (Arnold et al., 1988) times daily gave the same results
and there were no side effects. In a case of closed-cervix pyometra Memon and
Mickelsen (1993) started the treatment with very low doses (25 µg/kg). They ad-
ministered increasing doses to 250 µg/kg until the 4th day of therapy (7th treatment).
The observed side effects were overcome if the animal was walking. According to
Nelson (1993), a therapeutic regimen using 100 µg/kg of PGF2a initially, then
gradually increasing the dosage to 250 µg/kg over 48 to 72 h may allow the clini-
cian to assess the sensitivity of the dog to prostaglandin and allow the patient to
adapt to the drug. Jackson et al. (1982) administered prostaglandin analogues
(fluprostenol and cloprostenol) in a 24-h release intravaginal device for pregnancy
termination. Both analogues, used in a relatively low dosage (1025 µg/kg),
showed minimal acceptable side effects as compared with the aqueous marketed
form of cloprostenol administered intramuscularly. In our cases natural PGF2a
(150 µg/kg) and broad-spectrum bactericidal antibiotics were used intravaginally
and intramuscularly, respectively. After treatment, no side effects were observed,
and the recovery rate of dogs with metritis or pyometra (86.6%) was similar to the
previously published values (Sokolowski, 1980; Arnold et al., 1988). However, the
number of treatments performed by us was greater than reported previously
(Sokolowski, 1980). Further investigations are needed to determine the therapeutic
dose to be administered intravaginally and the necessary number of treatments.
Although this study was based on a relatively small number of cases (n = 17), it
can be concluded that intravaginally administered prostaglandin F2a may be a use-
ful means of treating bitches with metritis or pyometra. However, in severe cases
of pyometra ovariohysterectomy is needed.
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